Unity Biotechnology, Inc.
UBX
$0.745
-$0.065-8.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 31.88% | 34.80% | 36.05% | 8.92% | -30.93% |
| Total Depreciation and Amortization | -24.26% | -26.65% | -34.19% | -37.81% | -42.61% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -87.32% | -70.15% |
| Total Other Non-Cash Items | -76.05% | -83.57% | 53.03% | 122.42% | 153.25% |
| Change in Net Operating Assets | 422.76% | 177.23% | 197.79% | 201.43% | 83.21% |
| Cash from Operations | 28.80% | 43.74% | 45.39% | 45.66% | 36.51% |
| Capital Expenditure | -- | -- | 100.00% | 87.06% | 88.54% |
| Sale of Property, Plant, and Equipment | -94.78% | -77.39% | 30.84% | -37.67% | -64.55% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -29.40% | -85.86% | -57.99% | 593.08% | 1,306.70% |
| Cash from Investing | -29.65% | -85.84% | -57.73% | 607.53% | 1,155.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -418.43% | -- |
| Issuance of Common Stock | -98.46% | -98.54% | 1.23% | -91.84% | -90.77% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | 20.54% | 20.54% |
| Cash from Financing | 100.46% | 100.47% | 123.24% | -128.17% | -131.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.66% | -272.96% | 106.70% | -1,219.68% | -360.07% |